+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
ADC Drug CDMO Service Market - Global Forecast 2025-2030- Product Image
ADC Drug CDMO Service Market - Global Forecast 2025-2030- Product Image
Sale

ADC Drug CDMO Service Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 192 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6127992
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Antibody drug conjugate (ADC) contract development and manufacturing organizations (CDMOs) are transforming the oncology therapeutics landscape with advanced targeted therapies, combining monoclonal antibodies with potent cytotoxic payloads for greater treatment specificity and safety.

Market Snapshot: Antibody Drug Conjugate CDMO Services

The global ADC CDMO market is experiencing robust expansion, underpinned by increasing demand for scalable, turnkey development and manufacturing services. Market growth is propelled by the complexity of conjugation chemistry, emerging advancements in payload and linker technology, and tightening global regulatory requirements. As sponsors seek partners with full end-to-end service capabilities, leading providers are enhancing their technological infrastructure and investing in digital transformation to accelerate analytical and manufacturing processes.

Scope & Segmentation of the ADC CDMO Market

This research report delivers a detailed breakdown of the antibody drug conjugate CDMO sector across service types, process scales, technical approaches, therapeutic areas, end-user groups, and geographic regions.

  • Service Type: Includes analytical development, impurity testing, method validation, release testing, formulation (liquid and lyophilized), clinical and commercial manufacturing, process development for upstream and downstream activities, and stability studies.
  • Service Scale: Spans preclinical, clinical stage, and commercial stage contract manufacturing.
  • Conjugation Chemistry: Covers cysteine conjugation, lysine conjugation, and site-specific conjugation methods that impact drug-antibody ratio and therapeutic safety.
  • Therapeutic Application: Segments into hematological malignancies (leukemia, lymphoma, multiple myeloma) and solid tumors (notably breast and lung cancer).
  • End User: Addresses the needs of biotechnology companies, CDMOs, pharmaceutical companies, and research institutes with tailored service models and engagement structures.
  • Geographic Coverage: Encompasses Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including the United Kingdom, Germany, France, UAE, and more), and Asia-Pacific (China, India, Japan, Australia, South Korea, others).
  • Featured Companies: Analysis includes leaders such as Lonza Group AG, Catalent, Thermo Fisher, WuXi Biologics, Samsung Biologics, AGC Biologics, FUJIFILM Diosynth, Boehringer Ingelheim, Piramal Pharma, and Recipharm.

Key Takeaways: Strategic Insights for Senior Decision-Makers

  • Advances in site-specific conjugation and innovative linker technologies are reshaping CDMO value propositions in ADC development.
  • The rise of novel payload classes is driving rapid adaptation and process innovation among contract manufacturing partners.
  • Digital transformation, including AI-driven analytics and real-time data platforms, enables enhanced process control and streamlined regulatory submissions.
  • Integrated service offerings that cover analytical development, formulation, scale-up, and commercial manufacturing are increasingly prioritized by sponsors.
  • Collaborative approaches spanning virtual project teams and strategic alliances are enabling providers to achieve operational efficiency and improved client outcomes.
  • Regional regulatory differences and evolving market dynamics call for localized strategies to capture growth in both established and emerging markets.

Tariff Impact: Navigating United States Tariff Adjustments

Revised United States tariff schedules set for 2025 are expected to increase costs on imported ADC materials, driving CDMOs to implement risk mitigation strategies. These strategies include near-sourcing, renegotiation of supply terms, and adoption of bulk procurement models to stabilize input costs and minimize operational disruptions. Enhanced supply chain transparency and flexible manufacturing platforms will be critical for maintaining margin integrity and delivery continuity in the evolving regulatory climate.

Methodology & Data Sources

This report integrates primary interviews with industry executives, scientists, and regulatory experts, complemented by secondary data from proprietary databases, peer-reviewed literature, and industry white papers. A rigorous triangulation process validated all findings to reflect market realities and strategic priorities, with robust quality control throughout the analysis.

Why This Report Matters for Your ADC Strategy

  • Gain a clear view of emerging opportunities and challenges in the antibody drug conjugate CDMO ecosystem to inform investment and partnership decisions.
  • Leverage in-depth segmentation and regional perspectives to craft tailored go-to-market strategies aligned with local regulatory frameworks and infrastructure capacities.
  • Identify operational tactics and partnership models that can accelerate product development cycles and support regulatory compliance in the growing ADC space.

Conclusion

Antibody drug conjugate CDMO services are positioned at the forefront of oncology innovation. Informed strategic planning will enable organizations to harness new technologies, navigate tariff changes, and drive growth in this dynamic sector.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing demand for site-specific conjugation technologies driving CDMO partnerships
5.2. Integration of advanced linker-payload optimization platforms to enhance ADC efficacy
5.3. Emerging regulatory frameworks accelerating approval pathways for novel ADC manufacturing
5.4. Strategic collaborations between biotech firms and CDMOs to scale multistage ADC development
5.5. Adoption of single-use bioreactor systems to streamline ADC production and reduce contamination
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. ADC Drug CDMO Service Market, by Service Type
8.1. Introduction
8.2. Analytical Development
8.2.1. Impurity Testing
8.2.2. Method Development and Validation
8.2.3. Release Testing
8.3. Formulation Development
8.3.1. Liquid Formulation
8.3.2. Lyophilized Formulation
8.4. Manufacturing
8.4.1. Clinical Manufacturing
8.4.2. Commercial Manufacturing
8.5. Process Development
8.5.1. Downstream Development
8.5.2. Upstream Development
8.6. Stability Studies
9. ADC Drug CDMO Service Market, by Service Scale
9.1. Introduction
9.2. Clinical Stage
9.3. Commercial Stage
9.4. Preclinical Stage
10. ADC Drug CDMO Service Market, by Conjugation Chemistry
10.1. Introduction
10.2. Cysteine Conjugation
10.3. Lysine Conjugation
10.4. Site Specific Conjugation
11. ADC Drug CDMO Service Market, by Therapeutic Application
11.1. Introduction
11.2. Hematological
11.2.1. Leukemia
11.2.2. Lymphoma
11.2.3. Multiple Myeloma
11.3. Solid Tumor
11.3.1. Breast Cancer
11.3.2. Lung Cancer
12. ADC Drug CDMO Service Market, by End User
12.1. Introduction
12.2. Biotechnology Companies
12.3. Contract Manufacturing Organizations
12.4. Pharmaceutical Companies
12.5. Research Institutes
13. Americas ADC Drug CDMO Service Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa ADC Drug CDMO Service Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific ADC Drug CDMO Service Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Lonza Group AG
16.3.2. Catalent, Inc.
16.3.3. Thermo Fisher Scientific Inc.
16.3.4. WuXi Biologics Co., Ltd.
16.3.5. Samsung Biologics Co., Ltd.
16.3.6. AGC Biologics Co., Ltd.
16.3.7. FUJIFILM Diosynth Biotechnologies UK Limited
16.3.8. Boehringer Ingelheim GmbH
16.3.9. Piramal Pharma Limited
16.3.10. Recipharm AB
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. ADC DRUG CDMO SERVICE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY SERVICE SCALE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY SERVICE SCALE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY CONJUGATION CHEMISTRY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY CONJUGATION CHEMISTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ADC DRUG CDMO SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS ADC DRUG CDMO SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ADC DRUG CDMO SERVICE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES ADC DRUG CDMO SERVICE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ADC DRUG CDMO SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ADC DRUG CDMO SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ADC DRUG CDMO SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ADC DRUG CDMO SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ADC DRUG CDMO SERVICE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. ADC DRUG CDMO SERVICE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. ADC DRUG CDMO SERVICE MARKET: RESEARCHAI
FIGURE 26. ADC DRUG CDMO SERVICE MARKET: RESEARCHSTATISTICS
FIGURE 27. ADC DRUG CDMO SERVICE MARKET: RESEARCHCONTACTS
FIGURE 28. ADC DRUG CDMO SERVICE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ADC DRUG CDMO SERVICE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY ANALYTICAL DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY ANALYTICAL DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY IMPURITY TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY IMPURITY TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY METHOD DEVELOPMENT AND VALIDATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY METHOD DEVELOPMENT AND VALIDATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY RELEASE TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY RELEASE TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY FORMULATION DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY FORMULATION DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY LIQUID FORMULATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY LIQUID FORMULATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY LYOPHILIZED FORMULATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY LYOPHILIZED FORMULATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY FORMULATION DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY FORMULATION DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY CLINICAL MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY CLINICAL MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY COMMERCIAL MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY COMMERCIAL MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY PROCESS DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY PROCESS DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY DOWNSTREAM DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY DOWNSTREAM DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY UPSTREAM DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY UPSTREAM DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY PROCESS DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY STABILITY STUDIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY STABILITY STUDIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY SERVICE SCALE, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY SERVICE SCALE, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY CLINICAL STAGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY CLINICAL STAGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY COMMERCIAL STAGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY COMMERCIAL STAGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY PRECLINICAL STAGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY PRECLINICAL STAGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY CONJUGATION CHEMISTRY, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY CONJUGATION CHEMISTRY, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY CYSTEINE CONJUGATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY CYSTEINE CONJUGATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY LYSINE CONJUGATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY LYSINE CONJUGATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY SITE SPECIFIC CONJUGATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY SITE SPECIFIC CONJUGATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY HEMATOLOGICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY HEMATOLOGICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY LEUKEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY LEUKEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY LYMPHOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY MULTIPLE MYELOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY MULTIPLE MYELOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY HEMATOLOGICAL, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY HEMATOLOGICAL, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY SOLID TUMOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY SOLID TUMOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY BREAST CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY LUNG CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY SOLID TUMOR, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY SOLID TUMOR, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL ADC DRUG CDMO SERVICE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS ADC DRUG CDMO SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS ADC DRUG CDMO SERVICE MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS ADC DRUG CDMO SERVICE MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS ADC DRUG CDMO SERVICE MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS ADC DRUG CDMO SERVICE MARKET SIZE, BY FORMULATION DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS ADC DRUG CDMO SERVICE MARKET SIZE, BY FORMULATION DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS ADC DRUG CDMO SERVICE MARKET SIZE, BY MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS ADC DRUG CDMO SERVICE MARKET SIZE, BY MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS ADC DRUG CDMO SERVICE MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS ADC DRUG CDMO SERVICE MARKET SIZE, BY PROCESS DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS ADC DRUG CDMO SERVICE MARKET SIZE, BY SERVICE SCALE, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS ADC DRUG CDMO SERVICE MARKET SIZE, BY SERVICE SCALE, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS ADC DRUG CDMO SERVICE MARKET SIZE, BY CONJUGATION CHEMISTRY, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS ADC DRUG CDMO SERVICE MARKET SIZE, BY CONJUGATION CHEMISTRY, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS ADC DRUG CDMO SERVICE MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS ADC DRUG CDMO SERVICE MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS ADC DRUG CDMO SERVICE MARKET SIZE, BY HEMATOLOGICAL, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS ADC DRUG CDMO SERVICE MARKET SIZE, BY HEMATOLOGICAL, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS ADC DRUG CDMO SERVICE MARKET SIZE, BY SOLID TUMOR, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS ADC DRUG CDMO SERVICE MARKET SIZE, BY SOLID TUMOR, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS ADC DRUG CDMO SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS ADC DRUG CDMO SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS ADC DRUG CDMO SERVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS ADC DRUG CDMO SERVICE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES ADC DRUG CDMO SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES ADC DRUG CDMO SERVICE MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES ADC DRUG CDMO SERVICE MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES ADC DRUG CDMO SERVICE MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES ADC DRUG CDMO SERVICE MARKET SIZE, BY FORMULATION DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES ADC DRUG CDMO SERVICE MARKET SIZE, BY FORMULATION DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES ADC DRUG CDMO SERVICE MARKET SIZE, BY MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES ADC DRUG CDMO SERVICE MARKET SIZE, BY MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES ADC DRUG CDMO SERVICE MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES ADC DRUG CDMO SERVICE MARKET SIZE, BY PROCESS DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES ADC DRUG CDMO SERVICE MARKET SIZE, BY SERVICE SCALE, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES ADC DRUG CDMO SERVICE MARKET SIZE, BY SERVICE SCALE, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES ADC DRUG CDMO SERVICE MARKET SIZE, BY CONJUGATION CHEMISTRY, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES ADC DRUG CDMO SERVICE MARKET SIZE, BY CONJUGATION CHEMISTRY, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES ADC DRUG CDMO SERVICE MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES ADC DRUG CDMO SERVICE MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES ADC DRUG CDMO SERVICE MARKET SIZE, BY HEMATOLOGICAL, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES ADC DRUG CDMO SERVICE MARKET SIZE, BY HEMATOLOGICAL, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES ADC DRUG CDMO SERVICE MARKET SIZE, BY SOLID TUMOR, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES ADC DRUG CDMO SERVICE MARKET SIZE, BY SOLID TUMOR, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES ADC DRUG CDMO SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES ADC DRUG CDMO SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES ADC DRUG CDMO SERVICE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES ADC DRUG CDMO SERVICE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 141. CANADA ADC DRUG CDMO SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 142. CANADA ADC DRUG CDMO SERVICE MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 143. CANADA ADC DRUG CDMO SERVICE MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 144. CANADA ADC DRUG CDMO SERVICE MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 145. CANADA ADC DRUG CDMO SERVICE MARKET SIZE, BY FORMULATION DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 146. CANADA ADC DRUG CDMO SERVICE MARKET SIZE, BY FORMULATION DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 147. CANADA ADC DRUG CDMO SERVICE MARKET SIZE, BY MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 148. CANADA ADC DRUG CDMO SERVICE MARKET SIZE, BY MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 149. CANADA ADC DRUG CDMO SERVICE MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 150. CANADA ADC DRUG CDMO SERVICE MARKET SIZE, BY PROCESS DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 151. CANADA ADC DRUG CDMO SERVICE MARKET SIZE, BY SERVICE SCALE, 2018-2024 (USD MILLION)
TABLE 152. CANADA ADC DRUG CDMO SERVICE MARKET SIZE, BY SERVICE SCALE, 2025-2030 (USD MILLION)
TABLE 153. CANADA ADC DRUG CDMO SERVICE MARKET SIZE, BY CONJUGATION CHEMISTRY, 2018-2024 (USD MILLION)
TABLE 154. CANADA ADC DRUG CDMO SERVICE MARKET SIZE, BY CONJUGATION CHEMISTRY, 2025-2030 (USD MILLION)
TABLE 155. CANADA ADC DRUG CDMO SERVICE MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 156. CANADA ADC DRUG CDMO SERVICE MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 157. CANADA ADC DRUG CDMO SERVICE MARKET SIZE, BY HEMATOLOGICAL, 2018-2024 (USD MILLION)
TABLE 158. CANADA ADC DRUG CDMO SERVICE MARKET SIZE, BY HEMATOLOGICAL, 2025-2030 (USD MILLION)
TABLE 159. CANADA ADC DRUG CDMO SERVICE MARKET SIZE, BY SOLID TUMOR, 2018-2024 (USD MILLION)
TABLE 160. CANADA ADC DRUG CDMO SERVICE MARKET SIZE, BY SOLID TUMOR, 2025-2030 (USD MILLION)
TABLE 161. CANADA ADC DRUG CDMO SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. CANADA ADC DRUG CDMO SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. MEXICO ADC DRUG CDMO SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 164. MEXICO ADC DRUG CDMO SERVICE MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 165. MEXICO ADC DRUG CDMO SERVICE MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 166. MEXICO ADC DRUG CDMO SERVICE MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 167. MEXICO ADC DRUG CDMO SERVICE MARKET SIZE, BY FORMULATION DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 168. MEXICO ADC DRUG CDMO SERVICE MARKET SIZE, BY FORMULATION DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 169. MEXICO ADC DRUG CDMO SERVICE MARKET SIZE, BY MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 170. MEXICO ADC DRUG CDMO SERVICE MARKET SIZE, BY MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 171. MEXICO ADC DRUG CDMO SERVICE MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 172. MEXICO ADC DRUG CDMO SERVICE MARKET SIZE, BY PROCESS DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 173. MEXICO ADC DRUG CDMO SERVICE MARKET SIZE, BY SERVICE SCALE, 2018-2024 (USD MILLION)
TABLE 174. MEXICO ADC DRUG CDMO SERVICE MARKET SIZE, BY SERVICE SCALE, 2025-2030 (USD MILLION)
TABLE 175. MEXICO ADC DRUG CDMO SERVICE MARKET SIZE, BY CONJUGATION CHEMISTRY, 2018-2024 (USD MILLION)
TABLE 176. MEXICO ADC DRUG CDMO SERVICE MARKET SIZE, BY CONJUGATION CHEMISTRY, 2025-2030 (USD MILLION)
TABLE 177. MEXICO ADC DRUG CDMO SERVICE MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 178. MEXICO ADC DRUG CDMO SERVICE MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 179. MEXICO ADC DRUG CDMO SERVICE MARKET SIZE, BY HEMATOLOGICAL, 2018-2024 (USD MILLION)
TABLE 180. MEXICO ADC DRUG CDMO SERVICE MARKET SIZE, BY HEMATOLOGICAL, 2025-2030 (USD MILLION)
TABLE 181. MEXICO ADC DRUG CDMO SERVICE MARKET SIZE, BY SOLID TUMOR, 2018-2024 (USD MILLION)
TABLE 182. MEXICO ADC DRUG CDMO SERVICE MARKET SIZE, BY SOLID TUMOR, 2025-2030 (USD MILLION)
TABLE 183. MEXICO ADC DRUG CDMO SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 184. MEXICO ADC DRUG CDMO SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL ADC DRUG CDMO SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL ADC DRUG CDMO SERVICE MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL ADC DRUG CDMO SERVICE MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL ADC DRUG CDMO SERVICE MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL ADC DRUG CDMO SERVICE MARKET SIZE, BY FORMULATION DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL ADC DRUG CDMO SERVICE MARKET SIZE, BY FORMULATION DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL ADC DRUG CDMO SERVICE MARKET SIZE, BY MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL ADC DRUG CDMO SERVICE MARKET SIZE, BY MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL ADC DRUG CDMO SERVICE MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL ADC DRUG CDMO SERVICE MARKET SIZE, BY PROCESS DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL ADC DRUG CDMO SERVICE MARKET SIZE, BY SERVICE SCALE, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL ADC DRUG CDMO SERVICE MARKET SIZE, BY SERVICE SCALE, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL ADC DRUG CDMO SERVICE MARKET SIZE, BY CONJUGATION CHEMISTRY, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL ADC DRUG CDMO SERVICE MARKET SIZE, BY CONJUGATION CHEMISTRY, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL ADC DRUG CDMO SERVICE MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL ADC DRUG CDMO SERVICE MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL ADC DRUG CDMO SERVICE MARKET SIZE, BY HEMATOLOGICAL, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL ADC DRUG CDMO SERVICE MARKET SIZE, BY HEMATOLOGICAL, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL ADC DRUG CDMO SERVICE MARKET SIZE, BY SOLID TUMOR, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL ADC DRUG CDMO SERVICE MARKET SIZE, BY SOLID TUMOR, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL ADC DRUG CDMO SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL ADC DRUG CDMO SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA ADC DRUG CDMO SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA ADC DRUG CDMO SERVICE MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA ADC DRUG CDMO SERVICE MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA ADC DRUG CDMO SERVICE MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA ADC DRUG CDMO SERVICE MARKET SIZE, BY FORMULATION DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA ADC DRUG CDMO SERVICE MARKET SIZE, BY FORMULATION DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA ADC DRUG CDMO SERVICE MARKET SIZE, BY MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA ADC DRUG CDMO SERVICE MARKET SIZE, BY MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA ADC DRUG CDMO SERVICE MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA ADC DRUG CDMO SERVICE MARKET SIZE, BY PROCESS DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA ADC DRUG CDMO SERVICE MARKET SIZE, BY SERVICE SCALE, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA ADC DRUG CDMO SERVICE MARKET SIZE, BY SERVICE SCALE, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA ADC DRUG CDMO SERVICE MARKET SIZE, BY CONJUGATION CHEMISTRY, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA ADC DRUG CDMO SERVICE MARKET SIZE, BY CONJUGATION CHEMISTRY, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA ADC DRUG CDMO SERVICE MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA ADC DRUG CDMO SERVICE MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA ADC DRUG CDMO SERVICE MARKET SIZE, BY HEMATOLOGICAL, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA ADC DRUG CDMO SERVICE MARKET SIZE, BY HEMATOLOGICAL, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA ADC DRUG CDMO SERVICE MARKET SIZE, BY SOLID TUMOR, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA ADC DRUG CDMO SERVICE MARKET SIZE, BY SOLID TUMOR, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA ADC DRUG CDMO SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA ADC DRUG CDMO SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA ADC DRUG CDMO SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA ADC DRUG CDMO SERVICE MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA ADC DRUG CDMO SERVICE MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA ADC DRUG CDMO SERVICE MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA ADC DRUG CDMO SERVICE MARKET SIZE, BY FORMULATION DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA ADC DRUG CDMO SERVICE MARKET SIZE, BY FORMULATION DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA ADC DRUG CDMO SERVICE MARKET SIZE, BY MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA ADC DRUG CDMO SERVICE MARKET SIZE, BY MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA ADC DRUG CDMO SERVICE MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA ADC DRUG CDMO SERVICE MARKET SIZE, BY PROCESS DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA ADC DRUG CDMO SERVICE MARKET SIZE, BY SERVICE SCALE, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA ADC DRUG CDMO SERVICE MARKET SIZE, BY SERVICE SCALE, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA ADC DRUG CDMO SERVICE MARKET SIZE, BY CONJUGATION CHEMISTRY, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA ADC DRUG CDMO SERVICE MARKET SIZE, BY CONJUGATION CHEMISTRY, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA ADC DRUG CDMO SERVICE MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA ADC DRUG CDMO SERVICE MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA ADC DRUG CDMO SERVICE MARKET SIZE, BY HEMATOLOGICAL, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA ADC DRUG CDMO SERVICE MARKET SIZE, BY HEMATOLOGICAL, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA ADC DRUG CDMO SERVICE MARKET SIZE, BY SOLID TUMOR, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA ADC DRUG CDMO SERVICE MARKET SIZE, BY SOLID TUMOR, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA ADC DRUG CDMO SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA ADC DRUG CDMO SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA ADC DRUG CDMO SERVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA ADC DRUG CDMO SERVICE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM ADC DRUG CDMO SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 254. UNITED KINGDOM ADC DRUG CDMO SERVICE MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM ADC DRUG CDMO SERVICE MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM ADC DRUG CDMO SERVICE MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM ADC DRUG CDMO SERVICE MARKET SIZE, BY FORMULATION DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 258. UNITED KINGDOM ADC DRUG CDMO SERVICE MARKET SIZE, BY FORMULATION DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM ADC DRUG CDMO SERVICE MARKET SIZE, BY MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM ADC DRUG CDMO SERVICE MARKET SIZE, BY MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM ADC DRUG CDMO SERVICE MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM ADC DRUG CDMO SERVICE MARKET SIZE, BY PROCESS DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM ADC DRUG CDMO SERVICE MARKET SIZE, BY SERVICE SCALE, 2018-2024 (USD MILLION)
TABLE 264. UNITED KINGDOM ADC DRUG CDMO SERVICE MARKET SIZE, BY SERVICE SCALE, 2025-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM ADC DRUG CDMO SERVICE MARKET SIZE, BY CONJUGATION CHEMISTRY, 2018-2024 (USD MILLION)
TABLE 266. UNITED KINGDOM ADC DRUG CDMO SERVICE MARKET SIZE, BY CONJUGATION CHEMISTRY, 2025-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM ADC DRUG CDMO SERVICE MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 268. UNITED KINGDOM ADC DRUG CDMO SERVICE MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM ADC DRUG CDMO SERVICE MARKET SIZE, BY HEMATOLOGICAL, 2018-2024 (USD MILLION)
TABLE 270. UNITED KINGDOM ADC DRUG CDMO SERVICE MARKET SIZE, BY HEMATOLOGICAL, 2025-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM ADC DRUG CDMO SERVICE MARKET SIZE, BY SOLID TUMOR, 2018-2024 (USD MILLION)
TABLE 272. UNITED KINGDOM ADC DRUG CDMO SERVICE MARKET SIZE, BY SOLID TUMOR, 2025-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM ADC DRUG CDMO SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. UNITED KINGDOM ADC DRUG CDMO SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. GERMANY ADC DRUG CDMO SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 276. GERMANY ADC DRUG CDMO SERVICE MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 277. GERMANY ADC DRUG CDMO SERVICE MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 278. GERMANY ADC DRUG CDMO SERVICE MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 279. GERMANY ADC DRUG CDMO SERVICE MARKET SIZE, BY FORMULATION DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 280. GERMANY ADC DRUG CDMO SERVICE MARKET SIZE, BY FORMULATION DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 281. GERMANY ADC DRUG CDMO SERVICE MARKET SIZE, BY MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 282. GERMANY ADC DRUG CDMO SERVICE MARKET SIZE, BY MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 283. GERMANY ADC DRUG CDMO SERVICE MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 284. GERMANY ADC DRUG CDMO SERVICE MARKET SIZE, BY PROCESS DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 285. GERMANY ADC DRUG CDMO SERVICE MARKET SIZE, BY SERVICE SCALE, 2018-2024 (USD MILLION)
TABLE 286. GERMANY ADC DRUG CDMO SERVICE MARKET SIZE, BY SERVICE SCALE, 2025-2030 (USD MILLION)
TABLE 287. GERMANY ADC DRUG CDMO SERVICE MARKET SIZE, BY CONJUGATION CHEMISTRY, 2018-2024 (USD MILLION)
TABLE 288. GERMANY ADC DRUG CDMO SERVICE MARKET SIZE, BY CONJUGATION CHEMISTRY, 2025-2030 (USD MILLION)
TABLE 289. GERMANY ADC DRUG CDMO SERVICE MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 290. GERMANY ADC DRUG CDMO SERVICE MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 291. GERMANY ADC DRUG CDMO SERVICE MARKET SIZE, BY HEMATOLOGICAL, 2018-2024 (USD MILLION)
TABLE 292. GERMANY ADC DRUG CDMO SERVICE MARKET SIZE, BY HEMATOLOGICAL, 2025-2030 (USD MILLION)
TABLE 293. GERMANY ADC DRUG CDMO SERVICE MARKET SIZE, BY SOLID TUMOR, 2018-2024 (USD MILLION)
TABLE 294. GERMANY ADC DRUG CDMO SERVICE MARKET SIZE, BY SOLID TUMOR, 2025-2030 (USD MILLION)
TABLE 295. GERMANY ADC DRUG CDMO SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. GERMANY ADC DRUG CDMO SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. FRANCE ADC DRUG CDMO SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 298. FRANCE ADC DRUG CDMO SERVICE MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 299. FRANCE ADC DRUG CDMO SERVICE MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 300. FRANCE ADC DRUG CDMO SERVICE MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 301. FRANCE ADC DRUG CDMO SERVICE MARKET SIZE, BY FORMULATION DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 302. FRANCE ADC DRUG CDMO SERVICE MARKET SIZE, BY FORMULATION DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 303. FRANCE ADC DRUG CDMO SERVICE MARKET SIZE, BY MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 304. FRANCE ADC DRUG CDMO SERVICE MARKET SIZE, BY MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 305. FRANCE ADC DRUG CDMO SERVICE MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 306. FRANCE ADC DRUG CDMO SERVICE MARKET SIZE, BY PROCESS DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 307. FRANCE ADC DRUG CDMO SERVICE MARKET SIZE, BY SERVICE SCALE, 2018-2024 (USD MILLION)
TABLE 308. FRANCE ADC DRUG CDMO SERVICE MARKET SIZE, BY SERVICE SCALE, 2025-2030 (USD MILLION)
TABLE 309. FRANCE ADC DRUG CDMO SERVICE MARKET SIZE, BY CONJUGATION CHEMISTRY, 2018-2024 (USD MILLION)
TABLE 310. FRANCE ADC DRUG CDMO SERVICE MARKET SIZE, BY CONJUGATION CHEMISTRY, 2025-2030 (USD MILLION)
TABLE 311. FRANCE ADC DRUG CDMO SERVICE MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 312. FRANCE ADC DRUG CDMO SERVICE MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 313. FRANCE ADC DRUG CDMO SERVICE MARKET SIZE, BY HEMATOLOGICAL, 2018-2024 (USD MILLION)
TABLE 314. FRANCE ADC DRUG CDMO SERVICE MARKET SIZE, BY HEMATOLOGICAL, 2025-2030 (USD MILLION)
TABLE 315. FRANCE ADC DRUG CDMO SERVICE MARKET SIZE, BY SOLID TUMOR, 2018-2024 (USD MILLION)
TABLE 316. FRANCE ADC DRUG CDMO SERVICE MARKET SIZE, BY SOLID TUMOR, 2025-2030 (USD MILLION)
TABLE 317. FRANCE ADC DRUG CDMO SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 318. FRANCE ADC DRUG CDMO SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 319. RUSSIA ADC

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this ADC Drug CDMO Service market report include:
  • Lonza Group AG
  • Catalent, Inc.
  • Thermo Fisher Scientific Inc.
  • WuXi Biologics Co., Ltd.
  • Samsung Biologics Co., Ltd.
  • AGC Biologics Co., Ltd.
  • FUJIFILM Diosynth Biotechnologies UK Limited
  • Boehringer Ingelheim GmbH
  • Piramal Pharma Limited
  • Recipharm AB

Related Topics

Related Reports

Peptide-Drug Conjugates CDMO Service Market - Global Forecast 2025-2030 - Product Image

Peptide-Drug Conjugates CDMO Service Market - Global Forecast 2025-2030

  • Report
  • 193 Pages
  • Global
From
Large Molecule Drug Substance CDMO - Global Strategic Business Report - Product Image

Large Molecule Drug Substance CDMO - Global Strategic Business Report

  • Report
  • 378 Pages
  • Global
From
Sterile Injectables CDMO - Global Strategic Business Report - Product Image

Sterile Injectables CDMO - Global Strategic Business Report

  • Report
  • 586 Pages
  • Global
From
Oligonucleotide Drug CDMO Services Market - Global Forecast 2025-2030 - Product Image

Oligonucleotide Drug CDMO Services Market - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
Formulation Development Outsourcing: Market Share, and Growth Analysis by Product Type (Oral, Injectable, Topical), Application, End User, Technology - Product Image

Formulation Development Outsourcing: Market Share, and Growth Analysis by Product Type (Oral, Injectable, Topical), Application, End User, Technology

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.